Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies.

Wachholtz A, Gonzalez G, Boyer E, Naqvi ZN, Rosenbaum C, Ziedonis D.

Subst Abuse Rehabil. 2011 Aug 18;2:145-62. doi: 10.2147/SAR.S12944. eCollection 2011. Review.

PMID:
24474854
[PubMed]
Free PMC Article
2.

Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.

Blum K, Oscar-Berman M, Femino J, Waite RL, Benya L, Giordano J, Borsten J, Downs WB, Braverman ER, Loehmann R, Dushaj K, Han D, Simpatico T, Hauser M, Barh D, McLaughlin T.

J Addict Res Ther. 2013 Apr 23;4(2). doi: 10.4172/2155-6105.1000146.

PMID:
24273683
[PubMed]
Free PMC Article
3.

An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.

Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH.

Neuropsychopharmacology. 2013 Sep;38(10):2003-10. doi: 10.1038/npp.2013.99. Epub 2013 Apr 23. Erratum in: Neuropsychopharmacology. 2014 Mar;39(4):1039.

PMID:
23612435
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics.

Schaeffer T.

J Med Toxicol. 2012 Dec;8(4):400-7. doi: 10.1007/s13181-012-0270-y. Review.

PMID:
23073726
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Participant characteristics and buprenorphine dose.

Hillhouse M, Canamar CP, Doraimani G, Thomas C, Hasson A, Ling W.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):453-9. doi: 10.3109/00952990.2011.596974.

PMID:
21854290
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system.

Cropsey KL, Lane PS, Hale GJ, Jackson DO, Clark CB, Ingersoll KS, Islam MA, Stitzer ML.

Drug Alcohol Depend. 2011 Dec 15;119(3):172-8. doi: 10.1016/j.drugalcdep.2011.06.021. Epub 2011 Jul 23.

PMID:
21782352
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.

Middleton LS, Nuzzo PA, Lofwall MR, Moody DE, Walsh SL.

Addiction. 2011 Aug;106(8):1460-73. doi: 10.1111/j.1360-0443.2011.03424.x. Epub 2011 May 3.

PMID:
21395892
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers.

Duke AN, Correia CJ, Walsh SL, Bigelow GE, Strain EC.

Psychopharmacology (Berl). 2010 Aug;211(3):303-12. doi: 10.1007/s00213-010-1898-4. Epub 2010 Jun 25.

PMID:
20577717
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers.

Comer SD, Sullivan MA, Vosburg SK, Manubay J, Amass L, Cooper ZD, Saccone P, Kleber HD.

Addiction. 2010 Apr;105(4):709-18. doi: 10.1111/j.1360-0443.2009.02843.x. Erratum in: Addiction. 2010 Jul;105(7):1332.

PMID:
20403021
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes.

Hillhouse M, Domier CP, Chim D, Ling W.

J Addict Dis. 2010 Jan;29(1):23-9. doi: 10.1080/10550880903438925.

PMID:
20390696
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Buprenorphine tapering schedule and illicit opioid use.

Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C, Jenkins J, Hasson A, Annon J, Saxon A, Selzer J, Boverman J, Bilangi R.

Addiction. 2009 Feb;104(2):256-65. doi: 10.1111/j.1360-0443.2008.02455.x.

PMID:
19149822
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial.

Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Potter JS, Forman R, Vetter V, McNicholas L, Blaine J, Lynch KG, Fudala P.

JAMA. 2008 Nov 5;300(17):2003-11. doi: 10.1001/jama.2008.574. Erratum in: JAMA. 2009 Feb 25;301(8):830. JAMA. 2013 Apr 10;309(14):1461.

PMID:
18984887
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.

Magura S, Lee JD, Hershberger J, Joseph H, Marsch L, Shropshire C, Rosenblum A.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):222-30. doi: 10.1016/j.drugalcdep.2008.08.006. Epub 2008 Oct 18.

PMID:
18930603
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Penn/VA center for studies of addiction.

O'Brien CP, McLellan AT, Childress AR, Woody GE.

Neuropharmacology. 2009;56 Suppl 1:44-7. doi: 10.1016/j.neuropharm.2008.06.030. Epub 2008 Jun 26. Review.

PMID:
18625251
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Practical considerations for the clinical use of buprenorphine.

Jones HE.

Sci Pract Perspect. 2004 Aug;2(2):4-20. Review.

PMID:
18552728
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Narrative review: buprenorphine for opioid-dependent patients in office practice.

Sullivan LE, Fiellin DA.

Ann Intern Med. 2008 May 6;148(9):662-70. Review.

PMID:
18458279
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T.

Am J Addict. 2004;13 Suppl 1:S42-66.

PMID:
15204675
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers.

Comer SD, Collins ED.

J Pharmacol Exp Ther. 2002 Nov;303(2):695-703.

PMID:
12388653
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk